Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Textpert was a private digital health company focused on mental healthcare applications of artificial intelligence. The company developed AiME, an AI-driven avatar for mental evaluation and trend tracking intended to help users assess mood patterns and potential risk of depression. Public company-directory sources describe the business as an advice and health care startup headquartered in Los Angeles, California, and indicate that it has been permanently closed. Textpert does not appear to have operated as a traditional biotech or therapeutics developer, and there is no evidence of a drug pipeline or clinical-stage pharmaceutical programs. Its relevance to healthcare was in software-enabled mental health assessment rather than medicines, biologics, or medical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Textpert.